Adiso Therapeutics Information
Contact top employees from
Adiso Therapeutics
Summary
At Adiso, we create medicines to treat inflammatory diseases, improving the lives of patients and their families. Current treatment paradigms are far too often either inadequate to halt disease progre...Show more
Industries
Biotechnology
Headquarters Location
Employees Size
1-10 employees
Founded
2022
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2016 | Privately Held | 10-50 | - | $- | |
| - | Privately Held | 1-10 | - | $- | |
| 2020 | - | 1-10 | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at Adiso Therapeutics shows a diverse range of experience levels:
33% for 1–2 years33% for 3–4 years17% for 5–7 years17% for 8–10 yearsContact top employees from
Adiso Therapeutics
Rebecca Schaefer
Director, Clinical Operations
Susan Acton
Senior Director of Research at Adiso Therapeutics
Shannon Foley
VP Head of Finance
Renu Gupta
Consultant
Susan Acton
Head of Neuroinflammation Research
Andrew Peranick
Director, Corporate and Financial Strategy
Vidhi Khandelwal
Director, Program Management
Bharat Dixit
Chief Technology Officer
Rakesh Koutlekar
Director, CMC Operations (Small Molecules) - Remote
Jennifer Locke
Chief Operating & Business Officer
Dana Dexter
Senior Accountant
Scott Megaffin
Chief Executive Officer, Board Member, Adiso Therapeutics
Similar Companies
FAQ
Adiso Therapeutics operates in the Biotechnology industries. More details can be found on the official website: adisotx.com.
The headquarters of Adiso Therapeutics are located in Concord, United States.
Adiso Therapeutics currently employs 1-10 people.
Well-known competitors of Adiso Therapeutics include Bluefin BioMedicine, Dymedso and Prolocor.
